Treatment of sepsis: what changed during the last decades?
Reinhart
K
K
Department of Anesthesiology and Intensive Care Medicine, Friedrich-Schiller-University Jena, Germany.
Karzai
W
W
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001427:Bacterial Toxins / Q000037:antagonists & inhibitors; D015415:Biomarkers / Q000032:analysis; D001775:Blood Circulation; D002302:Cardiac Output; D003422:Critical Care; D004731:Endotoxins / Q000037:antagonists & inhibitors; D005440:Fluid Therapy; D006801:Humans; D007167:Immunotherapy; D010101:Oxygen Consumption; D018805:Sepsis / Q000175:diagnosis / Q000188:drug therapy / Q000382:microbiology / Q000628:therapy*; D018746:Systemic Inflammatory Response Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D014655:Vascular Resistance
D000276:Adjuvants, Immunologic; D000900:Anti-Bacterial Agents; D001427:Bacterial Toxins; D015415:Biomarkers; D004731:Endotoxins